These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10549863

  • 21. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
    Yoshida A, Yamamoto M, Irie T, Hirayama F, Uekama K.
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F, Mieda S, Miyamoto Y, Arima H, Uekama K.
    J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
    [Abstract] [Full Text] [Related]

  • 24. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
    Arima H, Adachi H, Irie T, Uekama K, Pitha J.
    Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
    Acartürk F, Imai T, Saito H, Ishikawa M, Otagiri M.
    J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
    [Abstract] [Full Text] [Related]

  • 27. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
    Abe K, Irie T, Uekama K.
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
    [Abstract] [Full Text] [Related]

  • 28. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
    Miyake K, Hirayama F, Uekama K.
    J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y, el-Said Aboutaleb A, Yamamoto K, Saleh SI, Ahmed MO.
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
    Ishiguro T, Morishita E, Iohara D, Hirayama F, Wada K, Motoyama K, Arima H, Uekama K.
    Int J Pharm; 2011 Oct 31; 419(1-2):161-9. PubMed ID: 21839823
    [Abstract] [Full Text] [Related]

  • 35. [Pharmaceutical application of cyclodextrins as multi-functional drug carriers].
    Uekama K.
    Yakugaku Zasshi; 2004 Dec 31; 124(12):909-35. PubMed ID: 15577263
    [Abstract] [Full Text] [Related]

  • 36. Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity.
    Matsuda H, Ito K, Sato Y, Yoshizawa D, Tanaka M, Taki A, Sumiyoshi H, Utsuki T, Hirayama F, Uekama K.
    Chem Pharm Bull (Tokyo); 1993 Aug 31; 41(8):1448-52. PubMed ID: 8403092
    [Abstract] [Full Text] [Related]

  • 37. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A, Yamamoto M, Itoh T, Irie T, Hirayama F, Uekama K.
    Chem Pharm Bull (Tokyo); 1990 Jan 31; 38(1):176-9. PubMed ID: 2337940
    [Abstract] [Full Text] [Related]

  • 38. Effect of 2,6-di-O-methyl-alpha-cyclodextrin on hemolysis and morphological change in rabbit's red blood cells.
    Motoyama K, Arima H, Toyodome H, Irie T, Hirayama F, Uekama K.
    Eur J Pharm Sci; 2006 Oct 01; 29(2):111-9. PubMed ID: 16870405
    [Abstract] [Full Text] [Related]

  • 39. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
    Sharma US, Balasubramanian SV, Straubinger RM.
    J Pharm Sci; 1995 Oct 01; 84(10):1223-30. PubMed ID: 8801338
    [Abstract] [Full Text] [Related]

  • 40. Peracylated beta-cyclodextrins as novel sustained-release carriers for a water-soluble drug, molsidomine.
    Uekama K, Horikawa T, Yamanaka M, Hirayama F.
    J Pharm Pharmacol; 1994 Sep 01; 46(9):714-7. PubMed ID: 7837039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.